Large-scale research studies have reported that up to 3 percent of
children and up to 8 percent of adolescents in the U.S. suffer from
depression, a serious mental disorder that adversely affects mood, energy,
interest, sleep, appetite, and overall functioning. In contrast to normal
emotional experiences of sadness or passing mood states, the symptoms of
depression are extreme and persistent and can interfere significantly with
the ability to function at home or at school. There is evidence that
depression emerging early in life often recurs and continues into
adulthood, and that early onset depression may predict more severe illness
in adult life. Diagnosing and treating children and adolescents with
depression is critical in preventing impairment in academic, social,
emotional, and behavioral functioning and to allow children to live up to
their full potential.
Depression in children and adolescents is associated with an increased
risk of suicidal behaviors. Since 1964, the suicide rate among adolescents
and young adults has doubled. In 1996, the most recent year for which
statistics are available, suicide was the 3rd leading cause of
death in 15 to 24 year olds and the 4th leading cause among 10
to 14 year olds.
Antidepressant medications are prescribed to treat children and
adolescents with depression. Recent studies indicate that certain
selective serotonin reuptake inhibitors (SSRIs) are safe and efficacious
treatments for depression in young people. However, care must be used in
prescribing and monitoring all medication. Special forms of psychotherapy,
such as cognitive-behavioral therapy, have proved effective for
adolescents with depression, and current studies are evaluating the
effectiveness of individual, family, and group therapies for young people.
A current multi-site study of adolescents who are depressed is evaluating
the comparative effectiveness of medication, psychosocial, or combined
treatments.
Information
provided by the National Institute of Mental Health